Drug Trial Radar · NCT05401357
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Last checked: Nov 20, 2026Latest source record: Aug 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
168
Planned (sponsor's estimate)
Start
Jun 29, 2022
Primary completion
Dec 2022
Study completion Dec 2022
Sponsor
- Lead sponsor
- Amneal Pharmaceuticals, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- CBCC Global Research
- First posted
- Jun 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with clinical endpoint in subjects with chronic open-angle glaucoma or ocular hypertension in both eyes. Test Product - Bimatoprost ophthalmic solution, 0.01% of Amneal EU, Limited Reference Product - LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of Allergan, Inc.
Conditions
- Glaucoma, Open-Angle
- Ocular Hypertension
Interventions
Test - Bimatoprost 0.01% Ophthalmic SolutionDrug
Subjects in one arm will receive one drop of the test drug in both the eyes every evening at approximately 10:00 pm ± 1 hour for 42 days.
Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)Drug
Subjects in the other arm will receive one drop of the reference drug in both the eyes every evening at approximately 10:00 pm for 42 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean difference in the intraocular pressure (IOP) of both eyes between the two treatment groups.Time frame: Day 14 and 42 at 00.00 hours, 04.00 hours, and 08.00 hours.
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Eye Research Foundation Inc.
Newport Beach, California · Recruiting
North Bay Eye Associates, Inc.
Petaluma, California · Recruiting
Volusia Eye Associates
New Smyrna Beach, Florida · Recruiting
Clayton Eye Clinical Research, LLC
Morrow, Georgia · Recruiting
Coastal Research Associates, LLC
Roswell, Georgia · Recruiting
Toyos Clinic
Nashville, Tennessee · Recruiting
Keystone Research
Austin, Texas · Not yet recruiting
Houston Eye Associates, North Loop
Houston, Texas · Recruiting
Cheyenne Eye Clinic & Surgery Center
Cheyenne, Wyoming · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.